Head-to-head · Cost-Efficiency Index
PepHaūs vs Care Bare Rx
Two GLP-1 programs on the bench, scored on the same six factors. Here's how their real cost of ownership compares — and which one we'd start with.
PepHaūs
People who want a verified all-50 program with both molecules disclosed and will pay mid-market for the peace of mind.
Visit PepHaūsCare Bare Rx
People consolidating several telehealth needs on one verified platform who are willing to commit to a 12-month plan to get the cheapest per-month rate.
Visit Care Bare RxThe verdict
PepHaūs takes it, leading the Cost-Efficiency Index 85 to 80. Mid-market $152/$246 pricing on both molecules, all-50 and LegitScript-verified — a clean, verified nationwide option that trades rock-bottom cost for a dependable pharmacy. Care Bare Rx still earns a B− — People consolidating several telehealth needs on one verified platform who are willing to commit to a 12-month plan to get the cheapest per-month rate.
Worth knowing either way: our overall #1 pick is CoreAge Rx (Cost-Efficiency Index 94/100 — the top of the ranking). See how it stacks up: CoreAge Rx vs PepHaūs.
Factor by factor
Both providers scored on our six Cost-Efficiency Index factors. The stronger side on each row is marked in teal.
Normalized Cost/Month
Price Transparency
Nationwide Access
Formulation Options
Clinical Oversight
Contract Flexibility
Pricing, coverage & formulary
The disclosed facts behind the scores. Lower price wins its row (teal).
| Spec | PepHaūs | Care Bare Rx |
|---|---|---|
| Cost-Efficiency Index | 85/100 | 80/100 |
| Semaglutide / mo | $152/mo | $199/mo month-to-month ($185/mo only on a 12-month prepay; the 3-month tier is dearer at $249/mo) |
| Tirzepatide / mo | $246/mo | $299/mo month-to-month ($293/mo only on a 12-month prepay; the 3-month tier is dearer at $356/mo) |
| Semaglutide / yr (modeled) | $1,824 | $2,388 |
| Tirzepatide / yr (modeled) | $2,952 | $3,588 |
| Coverage | All 50 states | All 50 states + Puerto Rico |
| Oral / sublingual | No | Yes |
| Brand-name access | Compounded only | Yes |
| Rank here | #19 | #25 |
PepHaūs
85/100Where the value is
- Both molecules disclosed at flat prices with nationwide all-50 access
- LegitScript-certified pharmacy behind the program
- Predictable pricing that's straightforward to model for a year
The tradeoffs
- $152/$246 is mid-market — undercut on raw cost by several verified all-50 rivals
- Compounded only — no brand-name or oral option
Care Bare Rx
80/100Where the value is
- LegitScript-certified and HIPAA-compliant, with both oral (Rybelsus, oral tirzepatide) and injectable options
- Real brand-name Ozempic available (from ~$705/mo) for anyone who specifically wants the on-label pen
- Coverage across all 50 states plus Puerto Rico — wider than most compounded telehealth options
The tradeoffs
- The 3-month plan is a real pricing trap — it costs more per month ($249 semaglutide / $356 tirzepatide) than either month-to-month or the 6-month plan
- The cheapest per-month rate requires a 12-month prepay commitment ($2,218 semaglutide / $3,518 tirzepatide total)
Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes the Cost-Efficiency Index. Pricing, states and verification reflect each provider's public disclosures at last review; prices change — confirm on the provider's site. Not medical advice. See our disclosure.